The following information was submitted:
Transactions: WSEAS TRANSACTIONS ON COMMUNICATIONS
Transactions ID Number: 28-205
Full Name: Chun-liang Lai
Position: Senior Lecturer
Age: ON
Sex: Male
Address: 123, Section 3, University Road, Douliou, Yunlin 64002, TAIWAN, R.O.C.
Country: TAIWAN
Tel: 886-4-24759386
Tel prefix:
Fax:
E-mail address: g9320801@yuntech.edu.tw
Other E-mails: clelai@seed.net.tw,clelai@sunrise.hk.edu.tw
Title of the Paper: Enhancing medication safety and reduce adverse drug events on inpatient medication administration using RFID
Authors as they appear in the Paper: Chun-liang Lai, Shou-wei Chien, Shiu-ching Chen, Kwoting Fang
Email addresses of all the authors: g9320801@yuntech.edu.tw,g9523809@yuntech.edu.tw,phar2993@mail.taic.doh.gov.tw,fangkt@yuntech.edu.tw
Number of paper pages: 10
Abstract: At any time, over 1.4 million people worldwide are suffering from infections acquired in hospital. Approximate 380,000 to 450,000 preventable Adverse drug events (ADEs) occurring annually in the United States. Therefore, patient safety has become a serious global public health issue. The purpose of this paper attempts to improve medication safety and reduce ADEs using RFID technology. For improvement of medical service quality in hospitals and reducing medication error, adopting RFID technologies has progressively become a trend. Medication errors and ADEs could be prevented by building a safer healthcare system. Accordingly, we developed the RFID on Inpatient Medication Administration System (RIMAS) and reengineering the inpatient medication processes. The RIMAS system integrating RFID into the existing Hospital Information Systems (HIS) may improve the efficiency of hospital management and medication safety, as well as decrease the risk of adverse drug events the!
reby increase higher quality of patient care.
Keywords: RFID, Patient safety, Medication safety, Medication error, Adverse drug events
EXTENSION of the file: .pdf
Special (Invited) Session: The application of RFID on inpatient medication administration to improve patient safety and reduce adverse drug events
Organizer of the Session: 594-570
How Did you learn about congress:
IP ADDRESS: 211.74.182.83
